Breaking News

CF PharmTech Raises $90M Investment

Aims to advance respiratory drug products in its pipeline to market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CF PharmTech, Inc., a pharmaceutical company focused on respiratory drug products, has raised a $90 million Series E investment led by New Alliance Capital. The investment will allow CF PharmTech to advance products in its pipeline to market.    New Alliance Capital Executive Director Lei Cai said, “New Alliance Capital prioritizes investment opportunities in the healthcare industries. Respiratory treatments and inhaled medications, in particular, are promising because of the high techno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters